bearish

Wuxi Biologics (2269.HK) - Dramatic Changes in Management Forecasts Fail to Bring Back Confidence

589 Views15 Jan 2024 08:55
In terms of the dramatic change in management's attitude towards project No., many people have doubts about the real intentions behind. We shared our interpretation. Let's hope it doesn't end too ugly
Boomeranged on Tue, 23 Jan 2024 09:37
Here are some new business updates: There are concerns about the size of the newly added orders last December, which may not deliver expected performance growth in 2024. Meanwhile, rumors said that Wuxi Bio has to slash prices in order to compete for domestic orders. Considering the current strong short sellers and low market sentiment, investors are advised not to rush to bottom-fish this stock.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
x